Home » VIVUS Receives $140,000,000 Milestone Payment
VIVUS Receives $140,000,000 Milestone Payment
VIVUS, Inc. announced that it has received a $140 million milestone payment from KV Pharmaceutical pursuant to the previously announced transfer of exclusive rights and assets related to Evamist.
Vivus
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May